Table 2. LC-MS/MS Quantification of Citalopram and the Metabolite Desmethylcitalopram in Brain and Seruma.
brain (μM) |
serum (μM) |
|||||
---|---|---|---|---|---|---|
45 min | 2 h | ANOVA | 45 min | 2 h | ANOVA | |
citalopram | 5.52 ± 0.54 | 2.85 ± 0.38 | * | 0.76 ± 0.04 | 0.42 ± 0.05 | * |
desmethylcitalopram | 0.38 ± 0.03 | 0.73 ± 0.12 | ** | 1.03 ± 0.04 | 0.51 ± 0.10 | * |
desmethylcitalopram from citalopram | 0.14 ± 0.01 | 0.37 ± 0.05 | * | 0.33 ± 0.01 | 0.46 ± 0.09 | n.s. |
Age-matched C57BL/6J mice were injected with either citalopram or desmethylcitalopram and sacrificed at 45 min or 2 h post-injection. The analytes were isolated from whole brain or serum and detected by LC-MS/MS (n ≥ 2 mice; values represent mean ± S.E.; one-way ANOVA with post-hoc Holm-Šídák multiple comparison test was used to compare 45 min to 2 h, *p < 0.05, **p < 0.01; n.s. not significant).